Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When will there be a generic loreev available?Does lipitor's effectiveness decrease with high fat meals?Pramlintide fda approval date?Symbravo ingredients mechanism of action?Dabrafenib patent expiration date novartis gsk composition matter?
See the DrugPatentWatch profile for Latisse
Latisse’s active ingredient is bimatoprost. [1]
Yes. Latisse = bimatoprost ophthalmic solution 0.03%. [1]
Latisse is a branded version of bimatoprost used to treat hypotrichosis (eyelash thinning). Any “generic Latisse” would refer to bimatoprost products, not a different drug name. [1]
You’ll typically see it described by the ingredient bimatoprost and the concentration (0.03%), rather than “Latisse.” [1] Sources: [1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021281
Other Questions About Latisse :